Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003–2006
Pernille Jorgensen(World Health Organization Regional Office for Europe), D Radun(Robert Koch Institute), Martin Schlaud(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Christina Poethko‐Müller(Robert Koch Institute), Wiebke Hellenbrand(Robert Koch Institute), W Thierfelder(Robert Koch Institute), Wolfgang Jilg(Institute of Medical Microbiology and Hygiene), Claudius U. Meyer(Robert Koch Institute)
Cited by 23
Related Papers
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
|BMC Infectious Diseases|2020|174